Skip to main content

GRFS · Grifols SA · Investor Relations

Track GRFS — free
$8.15 -0.05 (-0.61%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$5.55B
Shares
680.58M
Volume · Nov 20 848.3K Avg daily vol (3M) 622.34K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Past events

Date Event Type
2026-11-02 Q3 2026 Financial Results Results publication
2026-11-02 Grifols Investor Relations – Q3 2026 Earnings Call Transcript Earnings call
2026-07-28 H1 2026 Financial Results Results publication
2026-07-28 Earnings conference call (announced in 6-K) Earnings call
2026-06-18 Annual General Shareholders’ Meeting 2026 Shareholder meeting
2026-05-07 Q1 FY2026 Earnings conference call (announced in 6-K) Earnings call
2026-05-07 Q1 2026 Financial Results Results publication
2026-02-26 Full-Year 2025 Financial Results Results publication
2026-02-26 Earnings conference call (announced in 6-K) Earnings call
2025-11-04 Q3 2025 Financial Results Results publication
2025-11-04 Grifols Q3 Earnings Call Earnings call
2025-07-29 H1 2025 Financial Results Results publication
2025-07-29 Grifols Investor Relations – Q2 2025 Earnings Call Transcript Earnings call
2025-06-19 BIO International Convention Event
2025-06-05 Annual General Shareholders’ Meeting Shareholder meeting
2025-06-04 ISBT Congress Event
2025-05-21 International Plasma Protein Congress (IPPC) 2025 Event
2025-05-12 Q1 2025 Financial Results Results publication
2025-05-12 Grifols Investor Relations – Q1 2025 Earnings Call Transcript Earnings call
2025-04-24 World Orphan Drug Congress Event
2025-04-11 Pharma 2025 (Reuters Events) Event
2025-02-27 Capital Markets Day Presentation
2025-02-26 Full Year 2024 Financial Results Results publication
2025-01-16 J.P. Morgan Healthcare Conference Conference
2010-06-07 Analyst and investors' presentation regarding acquisition of Talecris Biotherapeutics Holdings Corp Presentation

Source: https://www.grifols.com/en/investors

Key facts CIK 1438569 CUSIP 398438408 13F (30d) 181 filings 153 filers Visit website Investor relations